New Insights into the Pathogenesis and Therapies of IgA Nephropathy

IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide and a frequent cause of kidney failure. Better understanding of the pathogenesis of IgAN and the related genetic, immunological, and cellular susceptibility factors are needed to enable the development of effectiv...

Full description

Bibliographic Details
Format: eBook
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
IgA
n/a
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication
LEADER 03282namaa2200913uu 4500
001 doab97463
003 oapen
005 20230220
006 m o d
007 cr|mn|---annan
008 230220s2022 xx |||||o ||| 0|eng d
020 |a 9783036550411 
020 |a 9783036550428 
020 |a books978-3-0365-5042-8 
024 7 |a 10.3390/books978-3-0365-5042-8  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
720 1 |a Suzuki, Hitoshi  |4 edt 
720 1 |a Novak, Jan  |4 edt 
720 1 |a Novak, Jan  |4 oth 
720 1 |a Suzuki, Hitoshi  |4 oth 
245 0 0 |a New Insights into the Pathogenesis and Therapies of IgA Nephropathy 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 online resource (194 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide and a frequent cause of kidney failure. Better understanding of the pathogenesis of IgAN and the related genetic, immunological, and cellular susceptibility factors are needed to enable the development of effective disease-specific therapy. This book brings together international experts to provide clinical and experimental studies and reviews with an emphasis on early diagnosis, prognosis, disease pathogenesis, determination of disease activity, and new strategies for treatment for IgAN. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine and Nursing  |2 bicssc 
653 |a aberrantly glycosylated IgA1 
653 |a adults 
653 |a autoantibody 
653 |a biomarker 
653 |a body mass index 
653 |a CD38 
653 |a children 
653 |a clinical trials 
653 |a complement 
653 |a complement C3 
653 |a crescents 
653 |a galactose-deficient IgA1 
653 |a genetics 
653 |a glomerular filtration rate 
653 |a glycosylation of IgA1 
653 |a IgA 
653 |a IgA nephropathy 
653 |a IgA Nephropathy 
653 |a IgA vasculitis 
653 |a IgA Vasculitis 
653 |a IgA1 
653 |a immune complex 
653 |a kidney 
653 |a kidney biopsy 
653 |a kidney mesangium 
653 |a KM55 
653 |a mesangial matrix expansion 
653 |a mouse model 
653 |a n/a 
653 |a nephritis 
653 |a nephrology 
653 |a O-glycosylation 
653 |a obesity 
653 |a Oxford score 
653 |a physiopathology 
653 |a plasma cells 
653 |a presentation 
653 |a prognosis 
653 |a proteinuria 
653 |a renal pathology 
653 |a treatment 
653 |a urinary galactose-deficient IgA1 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/97463  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/6023  |7 0  |z Open Access: DOAB, download the publication